Simpler, faster assays for infectious diseases

When your research requires insightful, high-quality data from microelectrode arrays (MEAs), Axion BioSystems’ MEA plates provide the right balance of throughput, electrode count, and ease of use for your experiments.

Balancing novelty and validity, the role of probability in target identification, and discussing the role of the genetic links to disease indications.

Target identification and validation forms the backbone of efforts to discover new drugs. Our expert panel discussed challenges and solutions in this field to drive safety and efficacy.

RAS mutations are the most common subfamily of oncogenes, so finding inhibitors could be extremely valuable to oncology research. However, they also make for particularly difficult targets. Andreas Mantoulidis explains how BI have been attempting to ‘drug the undruggable.’